On 4/19/2017, Shares of Ferro Corporation (NYSE:FOE) closed at $15.34 in last trading day. After noting the initial trading entry at $15.20, it reached to a day’s high of $15.50 and moved to a day’s low of $15.11. The recent daily volume was 476.28 thousand as contrast to it’s an average volume of 417.27 thousand.
The last close of the Ferro Corporation stock reflects that it traded up +4.53% from its 50-day moving average of $14.68. The stock traded above +6.91% to its 200-day MA of $14.35. Furthermore, it moved lower -5.13% from its 52-week high of $16.17 and +30.44% up from $11.76, which is 52-week low of the stock.
During the last month, Ferro Corporation’s (FOE) has changed 7.57% and performed 14.91% over the last 6 months. The mean rating score for this stock is at 2.30. This rating scale contains from 1 to 5 with 5 representing a Strong Sell, 1 signifying a Strong Buy and 3 demonstrating a Hold. The Volatility was noted at 2.61% in recent month and observed Weekly Volatility of 2.30%.
Ferro Corporation produces specialty materials in the United States and internationally. It operates through four business units: Tile Coating Systems; Porcelain Enamel; Performance Colors and Glass; and Pigments, Powders and Oxides. The company offers frits, porcelain and other glass enamels, glazes, stains, decorating colors, pigments, inks, polishing materials, dielectrics, electronic glasses, and other specialty coatings. Its products are used in appliances, automobiles, building and renovation, electronics, household furnishings, industrial products, and packaging. The company markets and sells its products directly, as well as through agents and distributors. It serves manufacturers of ceramic tile, major appliances, construction materials, automobile parts, automobiles, architectural and container glass, and electronic components and devices. Ferro Corporation was founded in 1919 and is headquartered in Mayfield Heights, Ohio.
Actinium Pharmaceuticals, Inc. (NYSEMKT:ATNM) finalized the last transaction at value of $1.51, with a daily change of -1.95% or -0.03 points. The company maintained volume of 449.66 thousand shares. In past trading day, the stock hit the maximum price of $1.55 and touched to minimum value of $1.49. It has a market cap of $ 84.27M.
As of last trade close, the stock is trading downside -31.05% from its one year high of $2.19 and moved +75.58% upward from $0.86, which is one year low of the stock.
The stock traded above +4.51% from its 50-day moving average of $1.44. Furthermore, the stock moved up +27.00% to its 200-day MA of $ 1.19.
Actinium Pharmaceuticals, Inc.’s (ATNM) moved with shift of 4.86% in the past week. Over the last three months, the shares of the company have changed 48.05% and performed 27.43% over the last six months. The stock currently has Monthly Volatility of 7.05% and Weekly Volatility of 4.63%.
April 18, 2017Actinium Pharmaceuticals, Inc. (NYSE MKT:ATNM) (“Actinium” or “the Company”), a biopharmaceutical Company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers, announced that Actinium is a sponsor of the Acute Leukemia Forum 2017 being held in San Francisco, California on Friday, April 21, 2017. The Acute Leukemia Forum is a continuing medical education (CME) event conducted by Hemedicus.
Actinium’s Chief Medical Officer Dr. Marker Berger said, “Since Actinium’s Phase 3 Iomab-B program and Phase 2 Actimab-A program both treat patients with acute myeloid leukemia, the Acute Leukemia Forum is an excellent opportunity for us to discuss our recent progress in these studies with many of the world’s leading experts in the field. We look forward to highlighting the highly differentiated approach and unmatched capabilities of our radioimmunotherapy drug candidates to the forum attendees.”